Cross Country Healthcare, Inc. (CCRN) Stock Analysis

Company Overview

Cross Country Healthcare, Inc. operates as a talent management provider within the United States healthcare sector, delivering critical staffing solutions through two primary segments: Nurse and Allied Staffing, and Physician Staffing. The company's core business model focuses on providing traditional staffing, recruiting, and value-added services to healthcare clients who require flexible workforce solutions. Operating within the broader Medical Care Facilities industry, this enterprise serves hospitals, outpatient facilities, and other healthcare entities that rely on specialized medical personnel. With a market capitalization of $320.72M and annual revenue reaching $1.05B, the firm demonstrates significant scale within the staffing niche. The presence of 7,890 employees underscores the operational magnitude required to manage complex logistics for nurse and allied health professionals across the country. These financial metrics collectively indicate that Cross Country Healthcare is a mid-to-large cap entity capable of influencing supply chain dynamics in the medical staffing market. The revenue figure of $1.05B reflects a substantial volume of transactions, while the market cap suggests a valuation that is currently sensitive to earnings volatility.

Financial Health

The company reported revenue of $1.05B for the trailing twelve months, yet it recorded a net income of -$94,852,000 and an EBITDA of $18.53M. The substantial divergence between the $1.05B in revenue and the -$94.85M net loss reveals a cost structure where operating expenses significantly outpace gross profits, resulting in a negative profit environment. Despite the net loss, the entity maintains positive EBITDA at $18.53M, suggesting that core operational cash generation exists before interest and tax impacts. Free cash flow stands at $42.77M, which indicates that the company possesses financial flexibility to service debt or pursue operational improvements despite reported accounting losses. The gross margin sits at 20.3%, while the operating margin is -0.6% and the profit margin is -9.0%, illustrating that the company struggles to convert gross revenue into bottom-line profitability. In terms of liquidity, the company holds $108.74M in cash against only $2.32M in debt, resulting in a conservative balance sheet profile. The debt-to-equity ratio is 0.72, further confirming low leverage, while a current ratio of 3.78 signals robust short-term liquidity and the ability to meet obligations with ease. Return on equity is -25.6% and return on assets is 0.3%, metrics that indicate management has yet to generate returns sufficient to cover the cost of equity or significantly utilize assets for profit generation.

Valuation Assessment

The trailing twelve-month P/E ratio is N/A due to negative earnings, while the forward P/E is 34.96, implying that the market prices in future earnings recovery rather than current profitability. The price-to-book ratio is 0.96, indicating that the market values the company at 96% of its book value, which often occurs when current earnings are depressed or negative. Alternative valuation metrics such as the price-to-sales ratio of 0.30 and an EV/EBITDA of 11.33 provide a clearer picture of valuation relative to revenue and cash flow generation. The stock trades between a 52-week high of $15.30 and a 52-week low of $7.43, placing the current price within a range that reflects significant price discovery and volatility. The beta of 0.40 suggests that the stock exhibits low volatility relative to the broader market, moving less than half as much as the S&P 500 during typical market swings. This low beta characteristic often appeals to investors seeking reduced exposure to systemic market risk, although the lack of dividends complicates total return potential. The forward P/E of 34.96 is notably higher than a traditional trailing multiple would suggest, highlighting the market's expectation of a future earnings turnaround.

Growth & Income

Revenue growth year-over-year declined by 23.6%, while earnings growth is N/A given the negative net income position. Since earnings are negative, they cannot grow faster than revenue in the traditional sense, and the contraction in revenue suggests a challenging operating environment or loss of market share. The company does not pay dividends, as evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning all available cash is retained for operations or debt reduction rather than distributed to shareholders. Consequently, the overall growth and income profile is defined by capital appreciation potential rather than income generation, with investors relying on the positive free cash flow to fund internal expansion. The absence of a dividend yield reinforces the nature of the business as a growth-oriented or turnaround play where profitability must be restored before cash can be returned to owners. The combination of negative profit margins and shrinking revenue creates a scenario where growth must be driven by efficiency gains or market expansion to reverse the current trajectory.